The latest price target for GE HealthCare Techs (NASDAQ:GEHC) was reported by Jefferies on January 8, 2025. The analyst firm set a price target for $103.00 expecting GEHC to rise to within 12 months (a possible 17.50% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for GE HealthCare Techs (NASDAQ:GEHC) was provided by Jefferies, and GE HealthCare Techs upgraded their buy rating.

The last upgrade for GE HealthCare Technologies Inc happened on January 8, 2025 when Jefferies raised their price target to $103. Jefferies previously had a hold for GE HealthCare Technologies Inc.

The last downgrade for GE HealthCare Technologies Inc happened on September 26, 2024 when UBS changed their price target from $84 to $74 for GE HealthCare Technologies Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE HealthCare Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE HealthCare Techs was filed on January 8, 2025 so you should expect the next rating to be made available sometime around January 8, 2026.

While ratings are subjective and will change, the latest GE HealthCare Techs (GEHC) rating was a upgraded with a price target of $95.00 to $103.00. The current price GE HealthCare Techs (GEHC) is trading at is $87.66, which is out of the analyst’s predicted range.